{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:54:58Z","timestamp":1783486498642,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pseudohypoparathyroidism (PHP), the first known post-receptorial hormone resistance, derives from a partial deficiency of the \u03b1 subunit of the stimulatory G protein (Gs\u03b1), a key component of the PTH\/PTHrP signaling pathway. Since its first description, different studies unveiled, beside the molecular basis for PHP, the existence of different subtypes and of diseases in differential diagnosis associated with genetic alterations in other genes of the PTH\/PTHrP pathway. The clinical and molecular overlap among PHP subtypes and with different but related disorders make both differential diagnosis and genetic counseling challenging. Recently, a proposal to group all these conditions under the novel term \u201cinactivating PTH\/PTHrP signaling disorders (iPPSD)\u201d was promoted and, soon afterwards, the first international consensus statement on the diagnosis and management of these disorders has been published. This review will focus on the major and minor features characterizing PHP\/iPPSDs as a group and on the specificities as well as the overlap associated with the most frequent subtypes.<\/jats:p>","DOI":"10.1007\/s12020-020-02533-9","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T17:02:50Z","timestamp":1605114170000},"page":"611-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?"],"prefix":"10.1007","volume":"72","author":[{"given":"Francesca Marta","family":"Elli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-3886","authenticated-orcid":false,"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"2533_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1210\/en.2012-1113","volume":"30","author":"F Albright","year":"1942","unstructured":"F. Albright et al. Pseudohypoparathyroidism: an example of \u2018Seabright-Bantam syndrome\u2019. Endocrinology 30, 922\u2013932 (1942). https:\/\/doi.org\/10.1210\/en.2012-1113","journal-title":"Endocrinology"},{"key":"2533_CR2","first-page":"337","volume":"65","author":"F Albright","year":"1952","unstructured":"F. Albright et al. Pseudopseudohypoparathyroidism. Trans. Assoc. Am. Physicians 65, 337\u2013350 (1952)","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"2533_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7326\/0003-4819-56-2-315","volume":"56","author":"JB Mann","year":"1962","unstructured":"J.B. Mann et al. Albright\u2019s hereditary osteodystrophy comprising pseudohypoparathyroidism and pseudopseudohypoparathyroidism: with a report of two cases representing the complete syndrome occurring in successive generations. Ann. Intern. Med. 56, 315\u2013342 (1962). https:\/\/doi.org\/10.7326\/0003-4819-56-2-315","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"2533_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/archderm.1971.04000240058008","volume":"104","author":"WG Eyre","year":"1971","unstructured":"W.G. Eyre, W.B. Reed, Albright\u2019s hereditary osteodystrophy with cutaneous bone formation. Arch. Dermatol. 104(6), 634\u2013642 (1971)","journal-title":"Arch. Dermatol."},{"issue":"2","key":"2533_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-105-2-197","volume":"105","author":"Z Farfel","year":"1986","unstructured":"Z. Farfel, E. Friedman, Mental deficiency in pseudohypoparathyroidism type I is associated with Ns\u2011protein deficiency. Ann. Intern. Med. 105(2), 197\u2013199 (1986). https:\/\/doi.org\/10.7326\/0003-4819-105-2-197","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"2533_CR6","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1073\/pnas.78.5.3098","volume":"78","author":"Z Farfel","year":"1981","unstructured":"Z. Farfel et al. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proc. Natl Acad. Sci. USA. 78(5), 3098\u20133102 (1981). https:\/\/doi.org\/10.1073\/pnas.78.5.3098","journal-title":"Proc. Natl Acad. Sci. USA."},{"issue":"1","key":"2533_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ajmg.1320110104","volume":"11","author":"N Fitch","year":"1982","unstructured":"N. Fitch, Albright\u2019s hereditary osteodystrophy: a review. Am. J. Med. Genet. 11(1), 11\u201329 (1982). https:\/\/doi.org\/10.1002\/ajmg.1320110104","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"2533_CR8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/s0022-3476(71)80196-8","volume":"79","author":"AG Weinberg","year":"1971","unstructured":"A.G. Weinberg, R.T. Stone, Autosomal dominant inheritance in Albright\u2019s hereditary osteodystrophy. J. Pediatr. 79(6), 996\u2013999 (1971). https:\/\/doi.org\/10.1016\/s0022-3476(71)80196-8","journal-title":"J. Pediatr."},{"key":"2533_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI10431","volume":"106","author":"J Liu","year":"2000","unstructured":"J. Liu et al. GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J. Clin. Invest. 106, 1167\u20131174 (2000). https:\/\/doi.org\/10.1172\/JCI10431","journal-title":"J. Clin. Invest."},{"issue":"8","key":"2533_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"G. Mantovani et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat. Rev. Endocrinol. 14(8), 476\u2013500 (2018). https:\/\/doi.org\/10.1038\/s41574-018-0042-0","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"2533_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1073\/pnas.56.4.1138","volume":"56","author":"A Tashjian","year":"1966","unstructured":"A. Tashjian et al. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc. Natl Acad. Sci. USA. 56(4), 1138\u20131142 (1966). https:\/\/doi.org\/10.1073\/pnas.56.4.1138","journal-title":"Proc. Natl Acad. Sci. USA."},{"issue":"10","key":"2533_CR12","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1172\/JCI106149","volume":"48","author":"LR Chase","year":"1969","unstructured":"L.R. Chase et al. Pseudohypoparathyroidism: defective excretion of 3\u0374,5\u0374\u2011AMP in response to parathyroid hormone. J. Clin. Invest. 48(10), 1832\u20131844 (1969). https:\/\/doi.org\/10.1172\/JCI106149","journal-title":"J. Clin. Invest."},{"issue":"3","key":"2533_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1210\/edrv-13-3-536","volume":"13","author":"AM Spiegel","year":"1992","unstructured":"A.M. Spiegel et al. Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr. Rev. 13(3), 536\u2013565 (1992). https:\/\/doi.org\/10.1210\/edrv-13-3-536","journal-title":"Endocr. Rev."},{"key":"2533_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s1040-7952(97)80019-5","volume":"31","author":"K Task\u00e9n","year":"1997","unstructured":"K. Task\u00e9n et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv. Second Messenger Phosphoprot. Res. 31, 191\u2013204 (1997). https:\/\/doi.org\/10.1016\/s1040-7952(97)80019-5","journal-title":"Adv. Second Messenger Phosphoprot. Res."},{"key":"2533_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1146\/annurev.bi.59.070190.004543","volume":"59","author":"SS Taylor","year":"1990","unstructured":"S.S. Taylor et al. cAMPdependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59, 971\u20131005 (1990). https:\/\/doi.org\/10.1146\/annurev.bi.59.070190.004543","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"2533_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ncpendmet0324","volume":"2","author":"AG Lania","year":"2006","unstructured":"A.G. Lania et al. Mechanisms of disease: mutations of G proteins and G\u2011protein-coupled receptors in endocrine diseases. Nat. Clin. Pract. Endocrinol. Metab. 2(12), 681\u2013693 (2006). https:\/\/doi.org\/10.1038\/ncpendmet0324","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"4","key":"2533_CR17","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0006-291x(80)90563-x","volume":"94","author":"MA Levine","year":"1980","unstructured":"M.A. Levine et al. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem. Biophys. Res. Commun. 94(4), 1319\u20131324 (1980). https:\/\/doi.org\/10.1016\/0006-291x(80)90563-x","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"2533_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJM199005173222002","volume":"322","author":"JL Patten","year":"1990","unstructured":"J.L. Patten et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright\u2019s hereditary osteodystrophy. N. Engl. J. Med. 322(20), 1412\u20131419 (1990). https:\/\/doi.org\/10.1056\/NEJM199005173222002","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"2533_CR19","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1073\/pnas.87.21.8287","volume":"87","author":"LS Weinstein","year":"1990","unstructured":"L.S. Weinstein et al. Mutations of the Gs \u03b1-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc. Natl Acad. Sci. USA 87(21), 8287\u20138290 (1990). https:\/\/doi.org\/10.1073\/pnas.87.21.8287","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"2","key":"2533_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/0888-7543(91)90164-a","volume":"11","author":"MA Levine","year":"1991","unstructured":"M.A. Levine et al. Mapping of the gene encoding the \u03b1 subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2\u2192q13.3 in human by in situ hybridization. Genomics 11(2), 478\u2013479 (1991). https:\/\/doi.org\/10.1016\/0888-7543(91)90164-a","journal-title":"Genomics"},{"issue":"2","key":"2533_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.30.2.101","volume":"30","author":"SJ Davies","year":"1993","unstructured":"S.J. Davies, H.E. Hughes, Imprinting in Albright\u2019s hereditary osteodystrophy. J. Med. Genet. 30(2), 101\u2013103 (1993). https:\/\/doi.org\/10.1136\/jmg.30.2.101","journal-title":"J. Med. Genet."},{"issue":"14","key":"2533_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/ajmg.a.32346","volume":"146A","author":"NS Adegbite","year":"2008","unstructured":"N.S. Adegbite et al. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS- based heterotopic ossification. Am. J. Med. Genet. A. 146A(14), 1788\u20131796 (2008). https:\/\/doi.org\/10.1002\/ajmg.a.32346","journal-title":"Am. J. Med. Genet. A."},{"issue":"15","key":"2533_CR23","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1073\/pnas.95.15.8715","volume":"95","author":"S Yu","year":"1998","unstructured":"S. Yu et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein \u03b1-subunit (Gs\u03b1) knockout mice is due to tissue-specific imprinting of the Gs\u03b1 gene. Proc. Natl Acad. Sci. USA. 95(15), 8715\u20138720 (1998). https:\/\/doi.org\/10.1073\/pnas.95.15.8715","journal-title":"Proc. Natl Acad. Sci. USA."},{"issue":"17","key":"2533_CR24","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1073\/pnas.95.17.10038","volume":"95","author":"BE Hayward","year":"1998","unstructured":"B.E. Hayward et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc. Natl Acad. Sci. USA. 95(17), 10038\u201310043 (1998). https:\/\/doi.org\/10.1073\/pnas.95.17.10038","journal-title":"Proc. Natl Acad. Sci. USA."},{"issue":"26","key":"2533_CR25","doi-asserted-by":"publisher","first-page":"15475","DOI":"10.1073\/pnas.95.26.15475","volume":"95","author":"BE Hayward","year":"1998","unstructured":"B.E. Hayward et al. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc. Natl Acad. Sci. USA. 95(26), 15475\u201315480 (1998). https:\/\/doi.org\/10.1073\/pnas.95.26.15475","journal-title":"Proc. Natl Acad. Sci. USA."},{"issue":"4","key":"2533_CR26","doi-asserted-by":"publisher","first-page":"F507","DOI":"10.1152\/ajprenal.2000.278.4.F507","volume":"278","author":"LS Weinstein","year":"2000","unstructured":"L.S. Weinstein et al. Variable imprinting of the heterotrimeric G protein Gs\u03b1-subunit within different segments of the nephron. Am. J. Physiol. Ren. Physiol. 278(4), F507\u2013F514 (2000). https:\/\/doi.org\/10.1152\/ajprenal.2000.278.4.F507","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"10","key":"2533_CR27","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1210\/jcem.86.10.7940","volume":"86","author":"H Zheng","year":"2001","unstructured":"H. Zheng et al. G\u03b1s transcripts are biallelically expressed in the human kidney cortex: implications for pseudohypoparathyroidism type 1b. J. Clin. Endocrinol. Metab. 86(10), 4627\u20134629 (2001). https:\/\/doi.org\/10.1210\/jcem.86.10.7940","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2533_CR28","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1210\/jc.2002-020183","volume":"87","author":"G Mantovani","year":"2002","unstructured":"G. Mantovani et al. The Gs\u03b1 gene: predominant maternal origin of transcription in human thyroid gland and gonads. J. Clin. Endocrinol. Metab. 87(10), 4736\u20134740 (2002). https:\/\/doi.org\/10.1210\/jc.2002-020183","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2533_CR29","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1210\/jc.2004-0558","volume":"89","author":"G Mantovani","year":"2004","unstructured":"G. Mantovani et al. Biallelic expression of the Gs\u03b1 gene in human bone and adipose tissue. J. Clin. Endocrinol. Metab. 89(12), 6316\u20136319 (2004). https:\/\/doi.org\/10.1210\/jc.2004-0558","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1-2","key":"2533_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2011.05.032","volume":"341","author":"S Klenke","year":"2011","unstructured":"S. Klenke et al. A novel aspect of GNAS imprinting: higher maternal expression of G\u03b1s in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol. Cell. Endocrinol. 341(1-2), 63\u201370 (2011). https:\/\/doi.org\/10.1016\/j.mce.2011.05.032","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"2533_CR31","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1210\/jc.2003-030393","volume":"88","author":"J Liu","year":"2003","unstructured":"J. Liu et al. The stimulatory G protein \u03b1\u2011subunit Gs\u03b1 is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J. Clin. Endocrinol. Metab. 88(9), 4336\u20134341 (2003). https:\/\/doi.org\/10.1210\/jc.2003-030393","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2533_CR32","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI19159","volume":"112","author":"M Bastepe","year":"2003","unstructured":"M. Bastepe et al. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J. Clin. Invest. 112, 1255\u20131263 (2003)","journal-title":"J. Clin. Invest."},{"issue":"1","key":"2533_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1487","volume":"37","author":"M Bastepe","year":"2005","unstructured":"M. Bastepe et al. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat. Genet. 37(1), 25\u201327 (2005). https:\/\/doi.org\/10.1038\/ng1487","journal-title":"Nat. Genet."},{"issue":"5","key":"2533_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1086\/429932","volume":"76","author":"A Linglart","year":"2005","unstructured":"A. Linglart et al. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am. J. Hum. Genet. 76(5), 804\u2013814 (2005). https:\/\/doi.org\/10.1086\/429932","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"2533_CR35","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2009-2205","volume":"95","author":"S Chillambhi","year":"2010","unstructured":"S. Chillambhi et al. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J. Clin. Endocrinol. Metab. 95(8), 3993\u20134002 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2205","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2533_CR36","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1210\/jc.2011-2804","volume":"97","author":"N Richard","year":"2012","unstructured":"N. Richard et al. A new deletion ablating NESP55 causes loss of maternal imprint of A\/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 97(5), E863\u2013E867 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2804","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2533_CR37","doi-asserted-by":"publisher","first-page":"E724","DOI":"10.1210\/jc.2013-3704","volume":"99","author":"FM Elli","year":"2014","unstructured":"F.M. Elli et al. Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A\/B DMR. J. Clin. Endocrinol. Metab. 99(4), E724\u2013E728 (2014). https:\/\/doi.org\/10.1210\/jc.2013-3704","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2533_CR38","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1210\/jc.2006-2287","volume":"92","author":"GP de Nanclares","year":"2007","unstructured":"G.P. de Nanclares et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright hereditary osteodystrophy. J. Clin. Endocrinol. Metab. 92(6), 2370\u20132373 (2007). https:\/\/doi.org\/10.1210\/jc.2006-2287","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2533_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1210\/jc.2007-0927","volume":"93","author":"V Mariot","year":"2008","unstructured":"V. Mariot et al. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J. Clin. Endocrinol. Metab. 93(3), 661\u2013665 (2008). https:\/\/doi.org\/10.1210\/jc.2007-0927","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2533_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/MAJ.0b013e31815b218f","volume":"336","author":"U Unluturk","year":"2008","unstructured":"U. Unluturk et al. Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type\u2011Ib in a patient with mild Albright hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am. J. Med. Sci. 336(1), 84\u201390 (2008). https:\/\/doi.org\/10.1097\/MAJ.0b013e31815b218f","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"2533_CR41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1210\/jc.2009-0176","volume":"95","author":"G Mantovani","year":"2010","unstructured":"G. Mantovani et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J. Clin. Endocrinol. Metab. 95(2), 651\u2013658 (2010). https:\/\/doi.org\/10.1210\/jc.2009-0176","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2533_CR42","doi-asserted-by":"publisher","first-page":"E1564","DOI":"10.1210\/jc.2013-4477","volume":"99","author":"B Brix","year":"2014","unstructured":"B. Brix et al. Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNASrelated disorders. J. Clin. Endocrinol. Metab. 99(8), E1564\u2013E1570 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4477","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2533_CR43","doi-asserted-by":"publisher","first-page":"E508","DOI":"10.1210\/jc.2013-3086","volume":"99","author":"FM Elli","year":"2014","unstructured":"F.M. Elli et al. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. J. Clin. Endocrinol. Metab. 99(3), E508\u2013E517 (2014). https:\/\/doi.org\/10.1210\/jc.2013-3086","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2533_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bone.2014.10.006","volume":"71","author":"S Turan","year":"2015","unstructured":"S. Turan et al. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS. Bone 71, 53\u201357 (2015). https:\/\/doi.org\/10.1016\/j.bone.2014.10.006","journal-title":"Bone"},{"issue":"23","key":"2533_CR45","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","volume":"364","author":"A Linglart","year":"2011","unstructured":"A. Linglart et al. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N. Engl. J. Med. 364(23), 2218\u20132226 (2011). https:\/\/doi.org\/10.1056\/NEJMoa1012717","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"2533_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ajhg.2012.03.003","volume":"90","author":"C Michot","year":"2012","unstructured":"C. Michot et al. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am. J. Hum. Genet. 90(4), 740\u2013745 (2012). https:\/\/doi.org\/10.1016\/j.ajhg.2012.03.003","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"2533_CR47","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.ajhg.2012.03.004","volume":"90","author":"H Lee","year":"2012","unstructured":"H. Lee et al. Exome sequencing identifies PDE4D mutations in acrodysostosis. Am. J. Hum. Genet. 90(4), 746\u2013751 (2012). https:\/\/doi.org\/10.1016\/j.ajhg.2012.03.004","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"2533_CR48","doi-asserted-by":"publisher","first-page":"E1808","DOI":"10.1210\/jc.2012-1369","volume":"97","author":"K Nagasaki","year":"2012","unstructured":"K. Nagasaki et al. PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance. Clin. Endocrinol. Metab. 97(9), E1808\u2013E1813 (2012). https:\/\/doi.org\/10.1210\/jc.2012-1369","journal-title":"Clin. Endocrinol. Metab."},{"issue":"12","key":"2533_CR49","doi-asserted-by":"publisher","first-page":"E2328","DOI":"10.1210\/jc.2012-2326","volume":"97","author":"A Linglart","year":"2012","unstructured":"A. Linglart et al. PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J. Clin. Endocrinol. Metab. 97(12), E2328\u2013E2338 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2326","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2533_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/humu.22222","volume":"34","author":"DC Lynch","year":"2013","unstructured":"D.C. Lynch et al. Identification of novel mutations confirms PDE4D as a major gene causing acrodysostosis. Hum. Mutat. 34(1), 97\u2013102 (2013). https:\/\/doi.org\/10.1002\/humu.22222","journal-title":"Hum. Mutat."},{"issue":"6","key":"2533_CR51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cge.12106","volume":"84","author":"F Muhn","year":"2013","unstructured":"F. Muhn et al. Novel mutations of the PRKAR1A gene in patients with acrodysostosis. Clin. Genet. 84(6), 531\u2013538 (2013). https:\/\/doi.org\/10.1111\/cge.12106","journal-title":"Clin. Genet."},{"issue":"1","key":"2533_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jmedgenet-2013-101937","volume":"51","author":"A Lindstrand","year":"2014","unstructured":"A. Lindstrand et al. Different mutations in PDE4D associated with developmental disorders with mirror phenotypes. J. Med. Genet. 51(1), 45\u201354 (2014). https:\/\/doi.org\/10.1136\/jmedgenet-2013-101937","journal-title":"J. Med. Genet."},{"issue":"11","key":"2533_CR53","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.cellsig.2014.07.025","volume":"26","author":"T Kaname","year":"2014","unstructured":"T. Kaname et al. Heterozygous mutations in cyclic AMP phosphodiesterase\u20114D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis. Cell. Signal. 26(11), 2446\u20132459 (2014). https:\/\/doi.org\/10.1016\/j.cellsig.2014.07.025","journal-title":"Cell. Signal."},{"issue":"8","key":"2533_CR54","doi-asserted-by":"publisher","first-page":"13267","DOI":"10.3390\/ijms150813267","volume":"15","author":"N Li","year":"2014","unstructured":"N. Li et al. The first mutation identified in a Chinese acrodysostosis patient confirms a p.G289E variation of PRKAR1A causes acrodysostosis. Int. J. Mol. Sci. 15(8), 13267\u201313274 (2014). https:\/\/doi.org\/10.3390\/ijms150813267","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"2533_CR55","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/ajmg.a.36669","volume":"164A","author":"T Mitsui","year":"2014","unstructured":"T. Mitsui et al. Acroscyphodysplasia as a phenotypic variation of pseudohypoparathyroidism and acrodysostosis type 2. Am. J. Med. Genet. A 164A(10), 2529\u20132534 (2014). https:\/\/doi.org\/10.1002\/ajmg.a.36669","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"2533_CR56","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-16-0107","volume":"175","author":"S Thiele","year":"2016","unstructured":"S. Thiele et al. From pseudohypoparathyroidism to inactivating PTH\/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur. J. Endocrinol. 175(6), P1\u2013P17 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0107","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"2533_CR57","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1359\/jbmr.2000.15.11.2074","volume":"15","author":"MC Eddy","year":"2000","unstructured":"M.C. Eddy et al. Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification. J. Bone Miner. Res. 15(11), 2074\u20132083 (2000). https:\/\/doi.org\/10.1359\/jbmr.2000.15.11.2074","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"2533_CR58","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1172\/JCI69746","volume":"123","author":"DM Cairns","year":"2013","unstructured":"D.M. Cairns et al. Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia. J. Clin. Invest. 123(8), 3624\u20133633 (2013). https:\/\/doi.org\/10.1172\/JCI69746","journal-title":"J. Clin. Invest."},{"issue":"4","key":"2533_CR59","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1210\/jc.2003-030850","volume":"89","author":"L de Sanctis","year":"2004","unstructured":"L. de Sanctis et al. Brachydactyly in 14 genetically characterized pseudohypoparathyroidism type Ia patients. J. Clin. Endocrinol. Metab. 89(4), 1650\u20131655 (2004). https:\/\/doi.org\/10.1210\/jc.2003-030850","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2533_CR60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0022-3476(85)80189-x","volume":"107","author":"MA Levine","year":"1985","unstructured":"M.A. Levine et al. Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia. J. Pediatr. 107(6), 919\u2013922 (1985). https:\/\/doi.org\/10.1016\/s0022-3476(85)80189-x","journal-title":"J. Pediatr."},{"issue":"4","key":"2533_CR61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1530\/eje.0.1480463","volume":"148","author":"J Pohlenz","year":"2003","unstructured":"J. Pohlenz et al. A new heterozygous mutation (L338N) in the human Gs\u03b1 (GNAS1) gene as a cause for congenital hypothyroidism in Albright\u2019s hereditary osteodystrophy. Eur. J. Endocrinol. 148(4), 463\u2013468 (2003). https:\/\/doi.org\/10.1530\/eje.0.1480463","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"2533_CR62","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1515\/jpem.2006.19.8.1049","volume":"19","author":"JE Pinsker","year":"2006","unstructured":"J.E. Pinsker et al. Pseudohypoparathyroidism type 1a with congenital hypothyroidism. J. Pediatr. Endocrinol. Metab. 19(8), 1049\u20131052 (2006). https:\/\/doi.org\/10.1515\/jpem.2006.19.8.1049","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"2533_CR63","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1210\/jc.2006-1497","volume":"92","author":"DN Long","year":"2007","unstructured":"D.N. Long et al. L. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J. Clin. Endocrinol. Metab. 92(3), 1073\u20131079 (2007). https:\/\/doi.org\/10.1210\/jc.2006-1497","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2533_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1365-2265.2000.00911.x","volume":"52","author":"KK Ong","year":"2000","unstructured":"K.K. Ong et al. Pseudohypoparathyroidism-another monogenic obesity syndrome. Clin. Endocrinol. 52(3), 389\u2013391 (2000). https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00911.x","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"2533_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrendo.2009.81","volume":"5","author":"BU Nwosu","year":"2009","unstructured":"B.U. Nwosu, M.M. Lee, Pseudohypoparathyroidism type 1a and insulin resistance in a child. Nat. Rev. Endocrinol. 5(6), 345\u2013350 (2009). https:\/\/doi.org\/10.1038\/nrendo.2009.81","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"2533_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4158\/EP.15.3.249","volume":"15","author":"BH Dekelbab","year":"2009","unstructured":"B.H. Dekelbab et al. Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr. Pract. 15(3), 249\u2013253 (2009). https:\/\/doi.org\/10.4158\/EP.15.3.249","journal-title":"Endocr. Pract."},{"issue":"1","key":"2533_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1687-9856-2014-21","volume":"2014","author":"L Wang","year":"2014","unstructured":"L. Wang, A.H. Shoemaker, Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study. Int. J. Pediatr. Endocrinol. 2014(1), 21 (2014). https:\/\/doi.org\/10.1186\/1687-9856-2014-21","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"8","key":"2533_CR68","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/jbmr.3450","volume":"33","author":"P Hanna","year":"2018","unstructured":"P. Hanna et al. Genetic and epigenetic defects at the GNAS locus lead to distinct patterns of skeletal growth but similar early-onset obesity. J. Bone Miner. Res. 33(8), 1480\u20131488 (2018). https:\/\/doi.org\/10.1002\/jbmr.3450","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"2533_CR69","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1210\/en.2012-1113","volume":"153","author":"M Chen","year":"2012","unstructured":"M. Chen et al. Gs\u03b1 deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gs\u03b1 mutations. Endocrinology 153(9), 4256\u20134265 (2012). https:\/\/doi.org\/10.1210\/en.2012-1113","journal-title":"Endocrinology"},{"issue":"8","key":"2533_CR70","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/ijo.2012.200","volume":"37","author":"AH Shoemaker","year":"2013","unstructured":"A.H. Shoemaker et al. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int. J. Obes. 2005 37(8), 1147\u20131153 (2013). https:\/\/doi.org\/10.1038\/ijo.2012.200","journal-title":"Int. J. Obes. 2005"},{"issue":"3","key":"2533_CR71","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1210\/jc.2015-3895","volume":"101","author":"JD Roizen","year":"2016","unstructured":"J.D. Roizen et al. Resting energy expenditure is decreased in pseudohypoparathyroidism Type 1A. J. Clin. Endocrinol. Metab. 101(3), 880\u2013888 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3895","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"41","key":"2533_CR72","doi-asserted-by":"publisher","first-page":"14794","DOI":"10.1073\/pnas.0405091101","volume":"101","author":"M Bastepe","year":"2004","unstructured":"M. Bastepe et al. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc. Natl Acad. Sci. USA. 101(41), 14794\u201314799 (2004). https:\/\/doi.org\/10.1073\/pnas.0405091101","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"2533_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4673","volume":"5","author":"AS Chagin","year":"2014","unstructured":"A.S. Chagin et al. G-protein stimulatory subunit alpha and Gq\/11\u03b1 G-proteins are both required to maintain quiescent stem-like chondrocytes. Nat. Commun. 5, 3673 (2014). https:\/\/doi.org\/10.1038\/ncomms4673","journal-title":"Nat. Commun."},{"issue":"8","key":"2533_CR74","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/ng1397","volume":"36","author":"A Plagge","year":"2004","unstructured":"A. Plagge et al. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat. Genet. 36(8), 818\u2013826 (2004). https:\/\/doi.org\/10.1038\/ng1397","journal-title":"Nat. Genet."},{"issue":"1","key":"2533_CR75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/acta.0.0930043","volume":"93","author":"G W\u00e4gar","year":"1980","unstructured":"G. W\u00e4gar et al. Pseudohypoparathyroidism associated with hypercalcitoninaemia. Acta Endocrinol. 93(1), 43\u201348 (1980). https:\/\/doi.org\/10.1530\/acta.0.0930043","journal-title":"Acta Endocrinol."},{"issue":"7","key":"2533_CR76","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1210\/jcem.86.7.7690","volume":"86","author":"V Vlaeminck-Guillem","year":"2001","unstructured":"V. Vlaeminck-Guillem et al. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J. Clin. Endocrinol. Metab. 86(7), 3091\u20133096 (2001). https:\/\/doi.org\/10.1210\/jcem.86.7.7690","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2533_CR77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jmg.31.10.779","volume":"31","author":"LC Wilson","year":"1994","unstructured":"L.C. Wilson, R.C. Trembath, Albright\u2019s hereditary osteodystrophy. J. Med. Genet. 31(10), 779\u2013784 (1994). https:\/\/doi.org\/10.1136\/jmg.31.10.779","journal-title":"J. Med. Genet."},{"issue":"4","key":"2533_CR78","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/adc.70.4.337","volume":"70","author":"DG Barr","year":"1994","unstructured":"D.G. Barr et al. Evolution of pseudohypoparathyroidism: an informative family study. Arch. Dis. Child. 70(4), 337\u2013338 (1994). https:\/\/doi.org\/10.1136\/adc.70.4.337","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"2533_CR79","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1210\/jc.2014-1674","volume":"99","author":"K Vir\u00e1gh","year":"2014","unstructured":"K. Vir\u00e1gh et al. Gradual development of brachydactyly in pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 99(6), 1945\u20131946 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1674","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2533_CR80","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4274\/jcrpe.2743","volume":"8","author":"S Kayemba-Kay\u2019s","year":"2016","unstructured":"S. Kayemba-Kay\u2019s et al. Pseudohypoparathyroidism Type 1A-subclinical hypothyroidism and rapid weight gain as early clinical signs: a clinical review of 10 cases. J. Clin. Res. Pediatr. Endocrinol. 8(4), 432\u2013438 (2016). https:\/\/doi.org\/10.4274\/jcrpe.2743","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"2","key":"2533_CR81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7326\/0003-4819-105-2-197","volume":"105","author":"Z Farfel","year":"1986","unstructured":"Z. Farfel, E. Friedman, Mental deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency. Ann. Intern. Med. 105(2), 197\u2013199 (1986). https:\/\/doi.org\/10.7326\/0003-4819-105-2-197","journal-title":"Ann. Intern. Med."},{"key":"2533_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/TACG.S51064","volume":"8","author":"RJ Pignolo","year":"2015","unstructured":"R.J. Pignolo et al. Progressive osseous heteroplasia: diagnosis, treatment, and prognosis. Appl. Clin. Genet. 8, 37\u201348 (2015). https:\/\/doi.org\/10.2147\/TACG.S51064","journal-title":"Appl. Clin. Genet."},{"issue":"4","key":"2533_CR83","doi-asserted-by":"publisher","first-page":"e1079","DOI":"10.1542\/peds.2014-2806","volume":"135","author":"P Romanet","year":"2015","unstructured":"P. Romanet et al. Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism. Pediatrics 135(4), e1079\u2013e1083 (2015). https:\/\/doi.org\/10.1542\/peds.2014-2806","journal-title":"Pediatrics"},{"issue":"5","key":"2533_CR84","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/jbmr.2408","volume":"30","author":"A Molinaro","year":"2015","unstructured":"A. Molinaro et al. TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib). J. Bone Miner. Res. 30(5), 906\u2013912 (2015). https:\/\/doi.org\/10.1002\/jbmr.2408","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"2533_CR85","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1210\/jc.2006-2287","volume":"92","author":"GP de Nanclares","year":"2007","unstructured":"G.P. de Nanclares et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright\u2019s hereditary osteodystrophy. J. Clin. Endocrinol. Metab. 92(6), 2370\u20132373 (2007). https:\/\/doi.org\/10.1210\/jc.2006-2287","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2533_CR86","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1210\/jc.2009-0176","volume":"95","author":"G Mantovani","year":"2010","unstructured":"G. Mantovani et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J. Clin. Endocrinol. Metab. 95(2), 651\u2013658 (2010). https:\/\/doi.org\/10.1210\/jc.2009-0176","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2533_CR87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2214\/ajr.128.1.95","volume":"128","author":"RC Ablow","year":"1977","unstructured":"R.C. Ablow et al. Acrodysostosis coinciding with pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. Am. J. Roentgenol. 128(1), 95\u201399 (1977). https:\/\/doi.org\/10.2214\/ajr.128.1.95","journal-title":"Am. J. Roentgenol."},{"issue":"4","key":"2533_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00019605-199210000-00003","volume":"1","author":"SJ Davies","year":"1992","unstructured":"S.J. Davies, H.E. Hughes, Familial acrodysostosis: can it be distinguished from Albright\u2019s hereditary osteodystrophy? Clin. Dysmorphol. 1(4), 207\u2013215 (1992)","journal-title":"Clin. Dysmorphol."},{"issue":"6","key":"2533_CR89","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/jbmr.2785","volume":"31","author":"FM Elli","year":"2016","unstructured":"F.M. Elli et al. Screening of PRKAR1A and PDE4D in a large Italian series of patients clinically diagnosed with albright hereditary osteodystrophy and\/or pseudohypoparathyroidism. J. Bone Miner. Res. 31(6), 1215\u20131224 (2016). https:\/\/doi.org\/10.1002\/jbmr.2785","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"2533_CR90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrendo.2016.52","volume":"12","author":"G Mantovani","year":"2016","unstructured":"G. Mantovani et al. Pseudohypoparathyroidism and Gs\u03b1-cAMP-linked disorders: current view and open issues. Nat. Rev. Endocrinol. 12(6), 347\u2013356 (2016). https:\/\/doi.org\/10.1038\/nrendo.2016.52","journal-title":"Nat. Rev. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02533-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:39:32Z","timestamp":1622119172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02533-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2533"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02533-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict ofinterest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}